European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera
Hemasphere
.
2022 May 11;6(6):e721.
doi: 10.1097/HS9.0000000000000721.
eCollection 2022 Jun.
Authors
Douglas Tremblay
1
,
Andrew Srisuwananukorn
1
,
Lukas Ronner
2
,
Nikolai Podoltsev
3
,
Jason Gotlib
4
,
Mark L Heaney
5
,
Andrew Kuykendall
6
,
Casey L O'Connell
7
,
Jamile M Shammo
8
,
Angela Fleischman
9
,
Ruben Mesa
10
,
Abdulraheem Yacoub
11
,
Ronald Hoffman
1
,
Erin Moshier
12
,
Nicole Zubizarreta
12
,
John Mascarenhas
1
Affiliations
1
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
2
Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
3
Hematology Section, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
4
Stanford University Medical Center, Palo Alto, CA, USA.
5
Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA.
6
Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
7
Jane Anne Nohl Division of Hematology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
8
Division of Hematology/Oncology, Rush University Medical Center, Chicago, IL, USA.
9
University of California, Irvine, CA, USA.
10
UT Health San Antonio Cancer Center, San Antonio, TX, USA.
11
The University of Kansas Cancer Center, Leawood, KS, USA.
12
Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
PMID:
35747843
PMCID:
PMC9208865
DOI:
10.1097/HS9.0000000000000721
No abstract available
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States